KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

BeOne Medicines (ONC) Net Income - Minority (2017 - 2020)

BeOne Medicines (ONC) has disclosed Net Income - Minority for 4 consecutive years, with -$19.6 million as the latest value for Q3 2020.

  • On a quarterly basis, Net Income - Minority fell 24.37% to -$19.6 million in Q3 2020 year-over-year; TTM through Sep 2020 was -$19.6 million, a 24.37% decrease, with the full-year FY2019 number at -$16.2 million, down 11.8% from a year prior.
  • Net Income - Minority was -$19.6 million for Q3 2020 at BeOne Medicines, down from -$10.2 million in the prior quarter.
  • In the past five years, Net Income - Minority ranged from a high of -$10.2 million in Q2 2020 to a low of -$19.6 million in Q3 2020.
  • A 4-year average of -$15.0 million and a median of -$14.6 million in 2018 define the central range for Net Income - Minority.
  • Biggest YoY gain for Net Income - Minority was 41.37% in 2020; the steepest drop was 24.37% in 2020.
  • BeOne Medicines' Net Income - Minority stood at -$14.4 million in 2017, then fell by 0.16% to -$14.4 million in 2018, then decreased by 11.8% to -$16.2 million in 2019, then dropped by 21.36% to -$19.6 million in 2020.
  • Per Business Quant, the three most recent readings for ONC's Net Income - Minority are -$19.6 million (Q3 2020), -$10.2 million (Q2 2020), and -$14.8 million (Q1 2020).